299 related articles for article (PubMed ID: 6413689)
21. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis.
Gonzalez-Gay MA; Rueda B; Vilchez JR; Lopez-Nevot MA; Robledo G; Ruiz MP; Fernández O; Garcia-Porrua C; Gonzalez-Escribano MF; Martín J
Rheumatology (Oxford); 2007 Mar; 46(3):431-4. PubMed ID: 17003171
[TBL] [Abstract][Full Text] [Related]
22. The association of HLA and immune responses to bovine collagen implants.
Vanderveen EE; McCoy JP; Schade W; Kapur JJ; Hamilton T; Ragsdale C; Grekin RC; Swanson NA
Arch Dermatol; 1986 Jun; 122(6):650-4. PubMed ID: 2424374
[TBL] [Abstract][Full Text] [Related]
23. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
Salvarani C; Casali B; Boiardi L; Ranzi A; Macchioni P; Nicoli D; Farnetti E; Brini M; Portioli I
J Rheumatol; 2000 May; 27(5):1215-21. PubMed ID: 10813290
[TBL] [Abstract][Full Text] [Related]
24. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis.
Weyand CM; Hunder NN; Hicok KC; Hunder GG; Goronzy JJ
Arthritis Rheum; 1994 Apr; 37(4):514-20. PubMed ID: 8147928
[TBL] [Abstract][Full Text] [Related]
25. Familial giant cell arteritis: report of an HLA-typed sibling pair and a review of the literature.
Wernick R; Davey M; Bonafede P
Clin Exp Rheumatol; 1994; 12(1):63-6. PubMed ID: 8162645
[TBL] [Abstract][Full Text] [Related]
26. Immunoglobulin (Gm) allotype frequencies in patients with giant bell arteritis and polymyalgia rheumatica.
Demaine AG; Vaughan RW; Behn AR; Myles AB; Panayi GS; Welsh KI
J Immunogenet; 1983 Oct; 10(5):343-8. PubMed ID: 6644068
[TBL] [Abstract][Full Text] [Related]
27. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms.
Mattey DL; Hajeer AH; Dababneh A; Thomson W; González-Gay MA; García-Porrúa C; Ollier WE
Arthritis Rheum; 2000 Aug; 43(8):1749-55. PubMed ID: 10943865
[TBL] [Abstract][Full Text] [Related]
28. HLA-DR4 in giant cell arteritis: association with polymyalgia rheumatica syndrome.
Richardson JE; Gladman DD; Fam A; Keystone EC
Arthritis Rheum; 1987 Nov; 30(11):1293-7. PubMed ID: 3500727
[TBL] [Abstract][Full Text] [Related]
29. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica.
González-Gay MA; Amoli MM; Garcia-Porrua C; Ollier WE
Semin Arthritis Rheum; 2003 Aug; 33(1):38-48. PubMed ID: 12920695
[TBL] [Abstract][Full Text] [Related]
30. [HLA typing and insulin antibody production in insulin-dependent diabetics].
Bruni B; Barolo P; Gadaleta G; Gamba Ansaldi S; Grassi G; Zerbinati A; Molinatti M; Salvetti E
Ann Osp Maria Vittoria Torino; 1984; 27(7-12):185-213. PubMed ID: 6443704
[TBL] [Abstract][Full Text] [Related]
31. Distribution of HLA (class I and class II) antigens in the native Dravidian Hindus of Tamil Nadu, south India.
Subramanian VS; Selvaraj P; Narayanan PR; Prabhakar R; Damodaran C
Gene Geogr; 1995 Apr; 9(1):15-24. PubMed ID: 8845335
[TBL] [Abstract][Full Text] [Related]
32. Letter: Distribution of HLA haplotypes in polymyalgia rheumatica.
Terasaki PI; Healey LA; Wilske KR
N Engl J Med; 1976 Oct; 295(16):905. PubMed ID: 958300
[No Abstract] [Full Text] [Related]
33. Human lymphocyte antigens characterizing psoriatic arthritis and its subtypes.
Gerber LH; Murray CL; Perlman SG; Barth WF; Decker JL; Nigra TA; Mann DL
J Rheumatol; 1982; 9(5):703-7. PubMed ID: 6816931
[TBL] [Abstract][Full Text] [Related]
34. In vitro lymphocyte proliferation response to therapeutic insulin components. Evidence for genetic control by the human major histocompatibility complex.
Mann DL; Mendell N; Kahn CR; Johnson AH; Rosenthal A
J Clin Invest; 1983 Sep; 72(3):1130-8. PubMed ID: 6411767
[TBL] [Abstract][Full Text] [Related]
35. Polymyalgia rheumatica: a syndrome associated with HLA-DR4 antigen.
Cid MC; Ercilla G; Vilaseca J; Sanmarti R; Villalta J; Ingelmo M; Urbano-Marquez A
Arthritis Rheum; 1988 May; 31(5):678-82. PubMed ID: 3259885
[TBL] [Abstract][Full Text] [Related]
36. [Genetic factors linked to the HLA system conferring increased susceptibility to acute lymphoblastic leukemia in children].
von Fliedner V; Mérica H; Jeannet M; Chapuis B; Feldges A; Imbach P; Wyss M
Schweiz Med Wochenschr; 1983 Oct; 113(40):1445-7. PubMed ID: 6417776
[TBL] [Abstract][Full Text] [Related]
37. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
[TBL] [Abstract][Full Text] [Related]
38. DR antigens in bullous pemphigoid.
Ahmed AR; Konqui A; Park MS; Tiwari JL; Terasaki PI
Arch Dermatol; 1984 Jun; 120(6):795. PubMed ID: 6372704
[No Abstract] [Full Text] [Related]
39. HLA-DR genotype risks in seropositive rheumatoid arthritis.
Legrand L; Lathrop GM; Marcelli-Barge A; Dryll A; Bardin T; Debeyre N; Poirier JC; Schmid M; Ryckewaert A; Dausset J
Am J Hum Genet; 1984 May; 36(3):690-9. PubMed ID: 6428222
[TBL] [Abstract][Full Text] [Related]
40. Antibodies to cardiolipin and beta 2 glycoprotein I in patients with polymyalgia rheumatica and giant cell arteritis.
Meyer O; Nicaise P; Moreau S; de Bandt M; Palazzo E; Hayem G; Chazerain P; Labarre C; Kahn MF
Rev Rhum Engl Ed; 1996 Apr; 63(4):241-7. PubMed ID: 8738442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
